Analyze Diet
International journal for parasitology. Drugs and drug resistance2020; 14; 99-104; doi: 10.1016/j.ijpddr.2020.09.004

Importation of macrocyclic lactone resistant cyathostomins on a US thoroughbred farm.

Abstract: Anthelmintic resistance in equine cyathostomins is both widespread and highly prevalent in the benzimidazole and tetrahydropyrimidine classes; however, reports of resistance to macrocyclic lactone (ML) drugs are sparse and sporadic. This study reports a case of clear ML resistance in a group of Thoroughbred yearlings imported from Ireland to the US in 2019. Fecal egg count reduction (FECR) following ivermectin administered in February 2020 demonstrated 100% reduction in the US bred yearlings, but 93.5%, 70.5%, and 74.5% reduction in three groups of the imported yearlings. The two former groups were then retreated with ivermectin, yielding FECRs of 33.8% and 23.5%, respectively. Horses from these two groups were then assigned randomly to two possible treatments; moxidectin or a triple combination of moxidectin, oxibendazole, and pyrantel pamoate. The groups treated with moxidectin had FECRs of 90.2%, 57.3%, and 50.0%, while the triple combination had a 100% FECR in all treated groups. Subsequently, the efficacy of ivermectin was reassessed in June 2020 yielding FECRs of 99.8%, 87.7%, and 62.0% in the three imported groups. The FECRs of the US bred yearlings all remained in the 99-100% range. This is the first study to clearly demonstrate ML resistance in cyathostomins and to confirm the suspicion through reassessment. These data demonstrate that ML-resistant cyathostomins were imported from Ireland and serve to illustrate that the global movement of horses has the potential to quickly spread ML-resistant parasite isolates around the world. The equine industry is strongly encouraged to routinely monitor anthelmintic efficacy, so occurrence of ML resistant cyathostomins can be detected and appropriate interventions implemented as early as possible.
Publication Date: 2020-09-30 PubMed ID: 33022574PubMed Central: PMC7548974DOI: 10.1016/j.ijpddr.2020.09.004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper discusses a case of imported macrocyclic lactone-resistant cyathostomins in a thoroughbred farm in the US. It highlights how resistance to anthelmintic drugs can be rapidly dispersed due to the global movement of horses.

Study Background

  • The study starts by acknowledging the global issue of anthelmintic resistance in cyathostomins. Cyathostomins are a type of parasitic worm that infect equines such as horses.
  • The most commonly observed resistance is against benzimidazole and tetrahydropyrimidine types of anthelmintics. However, macrocyclic lactones (ML), another type of anthelmintic, have shown resilience with sparse and sporadic reports of resistance.

Study Findings

  • The researchers discuss their investigation into a case of apparent ML resistance in Thoroughbred yearlings that were imported from Ireland to the US in 2019.
  • They conducted fecal egg count reduction (FECR) tests after administering ivermectin (an ML drug) and found that while the US-bred yearlings showed a 100% FECR, the imported yearlings showed lower FECRs of 93.5%, 70.5%, and 74.5% in three different groups.
  • The two groups showing the least response were treated with ivermectin again and showed 33.8% and 23.5% FECRs.
  • After an organized assignment of the poorly responding horses, they were treated with either moxidectin alone or a triple combination of moxidectin, oxibendazole, and pyrantel pamoate.
  • The FECRs improved in the groups treated with moxidectin (90.2%, 57.3%, and 50.0%) and the groups treated with the triple combination showed a complete (100%) FECR.
  • However, upon reassessment with ivermectin, the FECRs in the imported groups were again inadequate, validating the ML resistance.

Conclusions and Recommendations

  • This study is the first to highlight ML resistance in cyathostomins, underscoring the need for continuous monitoring and reassessment.
  • The results drive home the point that ML-resistant cyathostomins were imported from Ireland and these could be a source of rapid global dissemination of ML-resistant parasite isolates.
  • The authors call for a regular monitoring of anthelmintic efficacy to detect occurrences of ML-resistant cyathostomins and to implement appropriate interventions as early as possible to control the spread.

Cite This Article

APA
Nielsen MK, Banahan M, Kaplan RM. (2020). Importation of macrocyclic lactone resistant cyathostomins on a US thoroughbred farm. Int J Parasitol Drugs Drug Resist, 14, 99-104. https://doi.org/10.1016/j.ijpddr.2020.09.004

Publication

ISSN: 2211-3207
NlmUniqueID: 101576715
Country: Netherlands
Language: English
Volume: 14
Pages: 99-104

Researcher Affiliations

Nielsen, M K
  • M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY, USA. Electronic address: martin.nielsen@uky.edu.
Banahan, M
  • Godolphin, Jonabell Farm, 3333 Bowman Mill Road, Lexington, KY, USA.
Kaplan, R M
  • Department of Infectious Diseases, University of Georgia, GA, USA.

MeSH Terms

  • Animals
  • Anthelmintics / pharmacology
  • Drug Resistance
  • Farms
  • Feces
  • Horse Diseases / drug therapy
  • Horse Diseases / parasitology
  • Horses
  • Humans
  • Ireland
  • Ivermectin / therapeutic use
  • Lactones
  • Parasite Egg Count

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 37 references